glp 1 lawsuit Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs Pursuing a GLP-1 Drug Lawsuit
Description
Small observational studies and posthoc analyses of trials primarily designed for metabolic endpoints have hinted at mood improvements
GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice
In addition, GLP-1- exerts neuroprotective as well as cardioprotective role by reducing inflammation, stimulating nerve growth and affecting lipid metabolism (11, 13)
Less common risks include gallbladder disease and, in rare cases, pancreatitis
doi:10.1016/j.bbapap.2011.04.002 28
